Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance حسب Peng He (24579)

الموضوعات:

Supplementary Figure S2 from Circadian Clock Gene <i>Bmal1</i> Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell Carcinoma حسب Qingming Tang (397327)

Inotodiol decreases clone formation in HCC cells. حسب Yushuang Xing (20636685)

Gene set enrichment analysis (GSEA) suggests increased proliferation, decreased keratinocyte differentiation and decreased E-cadherin signaling in both the type 1 EBV-infected and... حسب Deo R. Singh (4784112)

Gene set enrichment analysis (GSEA) suggests increased proliferation, decreased keratinocyte differentiation and decreased E-cadherin signaling in both the type 1 EBV-infected and... حسب Deo R. Singh (4784112)

Supplementary Figure 1 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression حسب Thomas J. Rogers (8041841)

Tumor Microenvironment-Responsive Lipid Nanoparticle for Blocking Mitosis and Reducing Drug Resistance in NSCLC حسب Fengrui Yang (11187022)

الموضوعات:

<i>RPL22</i> is frequently deleted in CRC and its loss results in induction of its highly homologous paralog, Rpl22L1. حسب Shuyun Rao (449181)

الموضوعات:

Overexpression of TMEM182 renders human OSCC cells resistance to miR-450a-decreased cell adhesion. حسب En-Wei Hsing (154990)

RAP and LRP-1 silencing by siRNA decreased the level and density of lysosome in MCF-7R cells. حسب Aubery Henry (17060668)

Novel chromobox 2 inhibitory peptide decreases tumor progression حسب Lindsay W. Brubaker (15099942)

Rpl22L1 regulates the expression of DNA damage repair enzymes, MGMT and MLH1, which together with Rpl22L1 induction, contribute to poor prognosis. حسب Shuyun Rao (449181)

الموضوعات:

RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance حسب Shuyun Rao (449181)

الموضوعات:

Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis حسب Shaina F. Bruce (15091273)

"…Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…"

Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis حسب Shaina F. Bruce (15091273)

"…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…"

Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis حسب Shaina F. Bruce (15091273)

"…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…"

Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis حسب Shaina F. Bruce (15091273)

"…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…"

Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis حسب Shaina F. Bruce (15091273)

"…Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…"

Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis حسب Shaina F. Bruce (15091273)

"…Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…"

Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis حسب Shaina F. Bruce (15091273)

"…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…"